Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hyperlipoproteinemias

  Free Subscription


27.03.2017

12 Atherosclerosis
1 Curr Opin Lipidol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Atherosclerosis

  1. BOOT C, Holmes E, Neely RD
    Serum non-HDL cholesterol to apolipoprotein B ratio as a screening test for familial dysbetalipoproteinaemia (Type III hyperlipidaemia) in patients with mixed hyperlipidaemia.
    Atherosclerosis. 2016;255:7.
    PubMed     Text format    

  2. ASHFIELD-WATT P, Haralambos K, Edwards R, Townsend D, et al
    Estimation of the prevalence of cholesteryl ester storage disorder (CESD) in a cohort of patients with clinical features of familial hypercholesterolaemia.
    Atherosclerosis. 2016;255:1.
    PubMed     Text format    

  3. GELLATLY E
    Familial hypercholesterolaemia (FH) - Finding the needle in a haystack in a Scottish population.
    Atherosclerosis. 2016;255:2.
    PubMed     Text format    

  4. COZENS A, McMahon S, Purves J, Miedzybrodska Z, et al
    Detection, assessment and treatment of children with familial hypercholesterolaemia in Scotland.
    Atherosclerosis. 2016;255:2.
    PubMed     Text format    

  5. GRITZMACHER L, Bayly GR, Williams M, Hills A, et al
    The critical importance of segregation analysis in the management of patients and their families with suspected familial hypercholesterolaemia: 3 examples from the bristol FH clinic.
    Atherosclerosis. 2016;255:2-3.
    PubMed     Text format    

  6. LUNGLEY J, Jayne Z, Harvey D, Nair DR, et al
    Early identification of familial hypercholesterolaemIa (FH): The prevention of Cardiovascular disease (CVD).
    Atherosclerosis. 2016;255:3.
    PubMed     Text format    

  7. KATE HARALAMBOS K, Whitmore J
    Using pass database and geographic information systems (GIS) to map familial hypercholesterolaemia (FH) diagnoses in England and Wales.
    Atherosclerosis. 2016;255:3.
    PubMed     Text format    

  8. HILLS A, Honeychurch J, Davies J, Robinson C, et al
    4 years' cascade genetic testing for familial hypercholesterolaemia in England - Increased referrals and ascertainment.
    Atherosclerosis. 2016;255:3.
    PubMed     Text format    

  9. SHARIFI M, Jain A, Persaud J, Humphries SE, et al
    Cardiovascular biomarkers in monogenic familial hypercholesterolaemia and polygenic hypercholesterolaemia.
    Atherosclerosis. 2016;255:4.
    PubMed     Text format    

  10. GOYALE A, Jain A, Sharifi M, Gallivan A, et al
    Validation of low density lipoprotein correction factors in a multi-ethnic familial hypercholesterolaemia population at a North London lipid clinic.
    Atherosclerosis. 2016;255:6.
    PubMed     Text format    

  11. HONEYCHURCH J, Watson E, Hills A, Dean P, et al
    Validation and utility of a new NGS assay for familial hypercholesterolaemia incorporating 12 LDL-C-raising SNPs.
    Atherosclerosis. 2016;255:6-7.
    PubMed     Text format    

  12. HARALAMBOS K, Ashfield-Watt P, Edwards R, Gingell R, et al
    Five year experience of scoring criteria for familial hypercholesterolaemia (FH) genetic testing in wales: Should the criteria be refined to include age?
    Atherosclerosis. 2016;255:7-8.
    PubMed     Text format    


    Curr Opin Lipidol

  13. CALANDRA S, Tarugi P, Bertolini S
    Impact of rare variants in autosomal dominant hypercholesterolemia causing genes.
    Curr Opin Lipidol. 2017 Mar 18. doi: 10.1097/MOL.0000000000000414.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hyperlipoproteinemias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: